Mylan Can't Expedite Novartis Blood Transfusion IP Fight
A London judge has refused to expedite Novartis AG's lawsuit against Mylan over the rival drugmaker's plans to sell a generic version of its blood transfusion drug, saying its request to...To view the full article, register now.
Already a subscriber? Click here to view full article